Difficulty: Medium
Average Score: 70%
Practice
Filgrastim (human granulocyte colony-stimulating factor):
Correct answer
D
Rationale
Filgrastim stimulates proliferation and differentiation of myeloid progenitor cells (D), a G-CSF boosting neutrophil production, used post-chemotherapy to reduce neutropenia duration and infection risk. It's given subcutaneously (A), the standard route. It causes a transient neutrophil increase, not neutropenia (B is incorrect). It's not used in myeloid leukemia (C) treatment; it supports recovery. It causes bone pain (original E), from marrow expansion. Filgrastim's role in accelerating granulopoiesis is critical in oncology, shortening neutropenic periods, though leukocytosis and rare splenic rupture are concerns.